Italian pharmaceutical company DuLac Farmaceutici is moving to broaden its U.S. retail footprint after participating in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, held September 14-17 in Palm Beach Gardens, Florida. The company is now following up with prospective retail and distribution partners to explore product assortment and distribution opportunities across health, specialty, food, drug and mass retail channels. The push matters because it signals a shift from DuLac's established e-commerce base toward a more diversified, national retail presence in the competitive U.S. wellness market.
DuLac enters these discussions with products already available to American consumers through its Amazon business and via OneLavi. That existing presence provides a valuable reference point for buyers: the company's Arnica Gel 98% listing on Amazon.com has an average customer rating of 4.5 out of 5 stars, offering prospective partners tangible evidence of consumer acceptance as they evaluate the portfolio. The portfolio includes the high-concentration Arnica Gel 98% range, topical leg-care products, and the Dinaven and Diosmin lines, all reflecting DuLac's Italian manufacturing expertise and botanical formulation capabilities.
"Our priority following ECRM is to work with prospective partners to identify the DuLac products that best fit their customers and channels," said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. "We want to build lasting relationships by combining our Italian formulation and manufacturing expertise with a clear understanding of each partner's commercial needs." The meetings also introduced buyers to the research behind the products, including the proprietary Arnica Montana Arricchita project and advanced extraction technologies. Follow-up discussions will focus on product positioning and launch requirements for each prospective partner.
The implications extend beyond a single trade show. For a European company with more than 30 years of pharmaceutical industry experience, securing U.S. retail shelf space could accelerate brand recognition and provide a platform for sustained growth. DuLac's long-term objective is to establish itself as a nationally recognized U.S. brand across multiple channels, combining its European pharmacy heritage with the consumer traction it has already built online. The company's ability to translate its e-commerce momentum into brick-and-mortar distribution will be a key test of that strategy, and the outcome could shape how other Italian dermo-cosmetic makers approach the American market.
